Table 5. Occurrence of adverse effects during the experimental period in different groups.
Adverse effect | % of subjects | ||
---|---|---|---|
GC (n=15) | GAtb (n=15) | GProb (n=15) | |
Headache | 0 | 60% | 0 |
Stomachache | 0 | 7% | 0 |
Nausea or Vomiting | 0 | 27% | 0 |
Metallic taste in the mouth | 0 | 33% | 0 |
Diarrhea or abdominal pain | 0 | 27% | 0 |
Sleepiness | 0 | 20% | 0 |
Itchy skin | 0 | 0% | 0 |
Skin wounds | 0 | 0% | 0 |